Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
SB-334867 is an antagonist of the orexin 1 receptor (OX1R; KB = 39.8 nM) that is selective for OX1R over OX2R (KB = 1,995.3 nM).1 It reduces food intake and increases resting duration in rats, as well as inhibits orexin-A-induced increases in food intake, when administered at a dose of 30 mg/kg.2 SB-334867 (10 mg/kg) inhibits orexin-A-induced increases in grooming time in rats.1 It increases the seizure threshold in both the maximal electroshock seizure threshold (MEST) and 6 Hz psychomotor seizure test in mice when administered at doses of 30 and 3 mg/kg, respectively.3 Intracerebroventricular administration of SB-334867 (0.5-50 nmol) reduces morphine-induced analgesia in the formalin test in rats.4 SB-334867 (1.5 to 6 μg, intra-dentate gyrus injection) also reduces acquisition and consolidation of spatial memory in the Morris water maze in rats.5
WARNING This product is not for human or veterinary use.
1. Evidence that orexin-
2. SB-
3. SB 334867, a selective orexin receptor type 1 antagonist, elevates seizure threshold in mice. Life Sci. 150, 81-88 (2016).
4. Orexin receptor type-
5. The selective orexin 1 receptor antagonist SB-